-
1
-
-
0025266660
-
The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee
-
Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., et al. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172.
-
(1990)
Arthritis Rheum
, vol.33
, pp. 160-172
-
-
Wolfe, F.1
Smythe, H.A.2
Yunus, M.B.3
Bennett, R.M.4
Bombardier, C.5
Goldenberg, D.L.6
-
2
-
-
18844414588
-
The prevalence of fibromyalgia in women aged 20-64 in Turkey
-
Topbas M., Cakirbay H., Gulec H., Akgol E., Ak I., Can G. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol 2005, 34:140-144.
-
(2005)
Scand J Rheumatol
, vol.34
, pp. 140-144
-
-
Topbas, M.1
Cakirbay, H.2
Gulec, H.3
Akgol, E.4
Ak, I.5
Can, G.6
-
3
-
-
0028890678
-
The prevalence and characteristics of fibromyalgia in the general population
-
Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19-28.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 19-28
-
-
Wolfe, F.1
Ross, K.2
Anderson, J.3
Russell, I.J.4
Hebert, L.5
-
4
-
-
67650458711
-
Association between fibromyalgia and coronary heart disease and coronary catheterization
-
Ablin J.N., Beilinson N., Aloush V., Elkayam O., Finkelstein A. Association between fibromyalgia and coronary heart disease and coronary catheterization. Clin Cardiol 2009, 32(6):E7-E11.
-
(2009)
Clin Cardiol
, vol.32
, Issue.6
-
-
Ablin, J.N.1
Beilinson, N.2
Aloush, V.3
Elkayam, O.4
Finkelstein, A.5
-
5
-
-
77949365087
-
Assessment of myocardial function in patients with fibromyalgia and relationship to chronic emotional and physical stress
-
Cho K.I., Lee J.H., Lee H.G., Kim S.M., Kim T.I. Assessment of myocardial function in patients with fibromyalgia and relationship to chronic emotional and physical stress. Korean Circ J 2010, 40:74-80.
-
(2010)
Korean Circ J
, vol.40
, pp. 74-80
-
-
Cho, K.I.1
Lee, J.H.2
Lee, H.G.3
Kim, S.M.4
Kim, T.I.5
-
6
-
-
79952771739
-
Assessment of endothelial function in patients with fibromyalgia-cardiac ultrasound study
-
Oct 19. [Epub ahead of print].
-
Cho KI, Lee JH, Kim SM, Lee HG, Kim TI. Assessment of endothelial function in patients with fibromyalgia-cardiac ultrasound study. Clin Rheumatol 2010 Oct 19. [Epub ahead of print].
-
(2010)
Clin Rheumatol
-
-
Cho, K.I.1
Lee, J.H.2
Kim, S.M.3
Lee, H.G.4
Kim, T.I.5
-
7
-
-
33645501775
-
Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond
-
Boger R.H. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 2006, 38:126-136.
-
(2006)
Ann Med
, vol.38
, pp. 126-136
-
-
Boger, R.H.1
-
8
-
-
33947151033
-
Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis
-
Surdacki A., Martens-Lobenhoffer J., Wloch A., Marewicz E., Rakowski T., Wieczorek-Surdacka E., et al. Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2007, 56:809-819.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 809-819
-
-
Surdacki, A.1
Martens-Lobenhoffer, J.2
Wloch, A.3
Marewicz, E.4
Rakowski, T.5
Wieczorek-Surdacka, E.6
-
9
-
-
70349546855
-
Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis
-
Sari I., Kebapcilar L., Alacacioglu A., Bilgir O., Yildiz Y., Taylan A., et al. Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis. Intern Med 2009, 48:1363-1368.
-
(2009)
Intern Med
, vol.48
, pp. 1363-1368
-
-
Sari, I.1
Kebapcilar, L.2
Alacacioglu, A.3
Bilgir, O.4
Yildiz, Y.5
Taylan, A.6
-
10
-
-
33751223566
-
Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease
-
Sahin M., Arslan C., Naziroglu M., Tunc S.E., Demirci M., Sutcu R., et al. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. Ann Clin Lab Sci 2006, 36:449-454.
-
(2006)
Ann Clin Lab Sci
, vol.36
, pp. 449-454
-
-
Sahin, M.1
Arslan, C.2
Naziroglu, M.3
Tunc, S.E.4
Demirci, M.5
Sutcu, R.6
-
11
-
-
34249803311
-
Cytokine patterns in fibromyalgia and their correlation with clinical manifestations
-
Bazzichi L., Rossi A., Massimetti G., Giannaccini G., Giuliano T., De Feo F., et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007, 25:225-230.
-
(2007)
Clin Exp Rheumatol
, vol.25
, pp. 225-230
-
-
Bazzichi, L.1
Rossi, A.2
Massimetti, G.3
Giannaccini, G.4
Giuliano, T.5
De Feo, F.6
-
12
-
-
33645859615
-
Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide
-
Ozgocmen S., Ozyurt H., Sogut S., Akyol O. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int 2006, 26:585-597.
-
(2006)
Rheumatol Int
, vol.26
, pp. 585-597
-
-
Ozgocmen, S.1
Ozyurt, H.2
Sogut, S.3
Akyol, O.4
-
13
-
-
32144444753
-
Reduced tolerance of exercise in fibromyalgia may be a consequence of impaired microcirculation initiated by deficient action of nitric oxide
-
Kasikcioglu E., Dinler M., Berker E. Reduced tolerance of exercise in fibromyalgia may be a consequence of impaired microcirculation initiated by deficient action of nitric oxide. Med Hypotheses 2006, 66:950-962.
-
(2006)
Med Hypotheses
, vol.66
, pp. 950-962
-
-
Kasikcioglu, E.1
Dinler, M.2
Berker, E.3
-
14
-
-
74049159439
-
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases
-
Owczarek D., Cibor D., Mach T. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2010, 16:52-57.
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 52-57
-
-
Owczarek, D.1
Cibor, D.2
Mach, T.3
-
15
-
-
0141892585
-
Elevated plasma and urine levels of ADMA and 15(S)-8-iso-PGF2alpha in end-stage liver disease
-
Tsikas D., Rode I., Becker T., Nashan B., Klempnauer J., Frolich J.C. Elevated plasma and urine levels of ADMA and 15(S)-8-iso-PGF2alpha in end-stage liver disease. Hepatol (Baltim Md) 2003, 38:1063-1064.
-
(2003)
Hepatol (Baltim Md)
, vol.38
, pp. 1063-1064
-
-
Tsikas, D.1
Rode, I.2
Becker, T.3
Nashan, B.4
Klempnauer, J.5
Frolich, J.C.6
-
16
-
-
33947423436
-
Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure
-
Mookerjee R.P., Dalton R.N., Davies N.A., Hodges S.J., Turner C., Williams R., et al. Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure. Liver Transpl 2007, 13:400-405.
-
(2007)
Liver Transpl
, vol.13
, pp. 400-405
-
-
Mookerjee, R.P.1
Dalton, R.N.2
Davies, N.A.3
Hodges, S.J.4
Turner, C.5
Williams, R.6
-
17
-
-
0026165648
-
The fibromyalgia impact questionnaire: development and validation
-
Burckhardt C.S., Clark S.R., Bennett R.M. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991, 18:728-733.
-
(1991)
J Rheumatol
, vol.18
, pp. 728-733
-
-
Burckhardt, C.S.1
Clark, S.R.2
Bennett, R.M.3
-
18
-
-
0033635809
-
The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire
-
Sarmer S., Ergin S., Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000, 20:9-12.
-
(2000)
Rheumatol Int
, vol.20
, pp. 9-12
-
-
Sarmer, S.1
Ergin, S.2
Yavuzer, G.3
-
19
-
-
70350057304
-
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-an update on patient populations with a wide range of cardiovascular risk
-
Böger R.H., Maas R., Schulze F., Schwedhelm E. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 2009, 60:481-487.
-
(2009)
Pharmacol Res
, vol.60
, pp. 481-487
-
-
Böger, R.H.1
Maas, R.2
Schulze, F.3
Schwedhelm, E.4
-
20
-
-
0033594888
-
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase
-
Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999, 99:3092-3095.
-
(1999)
Circulation
, vol.99
, pp. 3092-3095
-
-
Ito, A.1
Tsao, P.S.2
Adimoolam, S.3
Kimoto, M.4
Ogawa, T.5
Cooke, J.P.6
-
21
-
-
34548103866
-
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases
-
Williams R.O., Paleolog E., Feldmann M. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol 2007, 7:412-417.
-
(2007)
Curr Opin Pharmacol
, vol.7
, pp. 412-417
-
-
Williams, R.O.1
Paleolog, E.2
Feldmann, M.3
-
22
-
-
47349104717
-
Circulating cytokine levels compared to pain in patients with fibromyalgia-a prospective longitudinal study over 6months
-
Wang H., Moser M., Schiltenwolf M., Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia-a prospective longitudinal study over 6months. J Rheumatol 2008, 35:1366-1370.
-
(2008)
J Rheumatol
, vol.35
, pp. 1366-1370
-
-
Wang, H.1
Moser, M.2
Schiltenwolf, M.3
Buchner, M.4
-
23
-
-
0034900001
-
Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study
-
Wallace D.J., Linker-Israeli M., Hallegua D., Silverman S., Silver D., Weisman M.H. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatol Oxf 2001, 40:743-749.
-
(2001)
Rheumatol Oxf
, vol.40
, pp. 743-749
-
-
Wallace, D.J.1
Linker-Israeli, M.2
Hallegua, D.3
Silverman, S.4
Silver, D.5
Weisman, M.H.6
-
24
-
-
0036163288
-
Cytokines and depression in cases with fibromyalgia
-
Gur A., Karakoc M., Nas K., Remzi Cevik, Denli A., Sarac J. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002, 29:358-361.
-
(2002)
J Rheumatol
, vol.29
, pp. 358-361
-
-
Gur, A.1
Karakoc, M.2
Nas, K.3
Remzi, C.4
Denli, A.5
Sarac, J.6
-
25
-
-
33947587688
-
Insights into oxidative stress: the isoprostanes
-
Montuschi P., Barnes P., Roberts L.J. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007, 14:703-717.
-
(2007)
Curr Med Chem
, vol.14
, pp. 703-717
-
-
Montuschi, P.1
Barnes, P.2
Roberts, L.J.3
-
26
-
-
0035011337
-
Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases
-
Basu S., Whiteman M., Mattey D.L., Halliwell B. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann Rheum Dis 2001, 60:627-631.
-
(2001)
Ann Rheum Dis
, vol.60
, pp. 627-631
-
-
Basu, S.1
Whiteman, M.2
Mattey, D.L.3
Halliwell, B.4
-
27
-
-
23444438707
-
Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms
-
Kennedy G., Spence V.A., McLaren M., Hill A., Underwood C., Belch J.J. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med 2005, 39:584-589.
-
(2005)
Free Radic Biol Med
, vol.39
, pp. 584-589
-
-
Kennedy, G.1
Spence, V.A.2
McLaren, M.3
Hill, A.4
Underwood, C.5
Belch, J.J.6
-
28
-
-
63349091068
-
Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study
-
Sendur O.F., Turan Y., Tastaban E., Yenisey C., Serter M. Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int 2009, 29:629-633.
-
(2009)
Rheumatol Int
, vol.29
, pp. 629-633
-
-
Sendur, O.F.1
Turan, Y.2
Tastaban, E.3
Yenisey, C.4
Serter, M.5
-
29
-
-
33645847273
-
Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns
-
Ozgocmen S., Ozyurt H., Sogut S., Akyol O., Ardicoglu O., Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 2006, 26:598-603.
-
(2006)
Rheumatol Int
, vol.26
, pp. 598-603
-
-
Ozgocmen, S.1
Ozyurt, H.2
Sogut, S.3
Akyol, O.4
Ardicoglu, O.5
Yildizhan, H.6
-
30
-
-
17744364057
-
Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?
-
Bagis S., Tamer L., Sahin G., Bilgin R., Guler H., Ercan B., et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?. Rheumatol Int 2005, 25:188-190.
-
(2005)
Rheumatol Int
, vol.25
, pp. 188-190
-
-
Bagis, S.1
Tamer, L.2
Sahin, G.3
Bilgin, R.4
Guler, H.5
Ercan, B.6
-
31
-
-
63649096922
-
Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia
-
Cordero M.D., Moreno-Fernandez A.M., deMiquel M., Bonal P., Campa F., Jimenez-Jimenez L.M., et al. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem 2009, 42:732-735.
-
(2009)
Clin Biochem
, vol.42
, pp. 732-735
-
-
Cordero, M.D.1
Moreno-Fernandez, A.M.2
deMiquel, M.3
Bonal, P.4
Campa, F.5
Jimenez-Jimenez, L.M.6
-
32
-
-
61549140096
-
Oxidative stress in fibromyalgia and its relationship to symptoms
-
Chung C.P., Titova D., Oeser A., Randels M., Avalos I., Milne G.L., et al. Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatol 2009, 28:435-438.
-
(2009)
Clin Rheumatol
, vol.28
, pp. 435-438
-
-
Chung, C.P.1
Titova, D.2
Oeser, A.3
Randels, M.4
Avalos, I.5
Milne, G.L.6
-
33
-
-
1242273844
-
ADMA and oxidative stress
-
Sydow K., Munzel T. ADMA and oxidative stress. Atherosclerosis 2003, 4:41-51.
-
(2003)
Atherosclerosis
, vol.4
, pp. 41-51
-
-
Sydow, K.1
Munzel, T.2
|